VirnetX Holding Corporation — FY 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014. The filing is an annual report, not a standalone fourth-quarter filing; quarterly figures are included. Unless otherwise noted, financial amounts below are in millions of dollars.
Business context
VirnetX develops and licenses patented technology for secure Internet communications, including its GABRIEL platform and secure-domain-name technology. In 2014, the company’s revenue remained primarily patent royalties and license-related amounts; its Gabriel products were in public beta and not yet generally available. The company reported approximately 39 U.S. and 66 foreign patents, with about 75 applications pending.
Financial performance and liquidity
| Metric | FY 2014 | FY 2013 |
|---|---|---|
| Revenue | $1.249 | $2.197 |
| Gain on settlement | $23.000 | — |
| Operating expenses, after settlement gain | $13.414 | $30.784 |
| Operating loss | $(12.165) | $(28.587) |
| Net loss | $(9.902) | $(27.608) |
| Loss per share | $(0.19) | $(0.54) |
| Cash from operating activities | $1.967 | $(7.284) |
Revenue fell 43% year over year. The $23 million Microsoft settlement was recorded as a gain on settlement, not revenue, and materially affected reported results. The company also recorded $6.1 million of royalty expense payable to Leidos related to that settlement. Excluding the settlement gain, operating performance remained loss-making. Gross margin is not applicable to this licensing-focused business.
Fourth-quarter 2014 revenue was $0.439 million; the quarter included the $23 million settlement gain and reported operating income of $6.870 million and net income of $7.325 million. The first three quarters each reported net losses.
At year-end, cash and cash equivalents were $18.658 million and available-for-sale investments were $22.571 million, totaling $41.229 million in cash and investments. Current assets were $41.882 million versus current liabilities of $11.963 million. The balance sheet reported no long-term debt or long-term obligations. Stockholders’ equity was $32.627 million, down from $34.024 million. The company reported no off-balance-sheet arrangements.
Operating cash flow improved from the prior year, partly reflecting settlement-related payable and working-capital movements; cash and cash equivalents nevertheless declined by $0.515 million. Management said available cash was sufficient for short-term needs, while expecting continued near-term net losses and substantial legal costs.
Material changes and unusual items
- Microsoft paid $23 million in December 2014 to settle a subsequent patent dispute and expand its license. The amended agreement raised cumulative Microsoft cash settlements to $223 million and granted Microsoft a worldwide, irrevocable, nonexclusive, royalty-free, fully paid-up license to all VirnetX patents.
- Research and development expense rose to $2.004 million from $1.782 million; selling, general and administrative expense declined to $28.310 million from $29.002 million, primarily reflecting lower legal fees. Legal fees were $14.012 million, compared with $16.363 million.
- A noncash gain of $2.238 million resulted from revaluing Series I warrant liabilities, versus a $1.608 million gain in 2013. The year-end derivative liability was $0.320 million; approximately 157,000 warrants remained outstanding and were due to expire in March 2015.
- The company prepaid $4 million for a facility lease used for promotional and marketing purposes, amortized over a 10-year term; $3.144 million was reported as a noncurrent prepaid expense at year-end. It also incurred approximately $0.296 million in 2014 aircraft rental costs from an entity controlled by its CEO and Chief Administrative Officer.
- Outstanding options and restricted stock units totaled approximately 4.8 million shares at year-end; potential dilution is relevant, particularly given the share price decline.
Outlook, risks and contingencies
Management expected general public release of the Gabriel platform and collaboration products in the first half of 2015, subject to successful completion of public beta testing. It provided no quantitative revenue or earnings guidance. Its strategy is to expand patent licensing, develop secure-domain-name registry services, and commercialize products; success depends on winning licensees and customers and converting beta testing into sales.
Three patent infringement lawsuits against Apple remained pending. In the earlier Apple case, the Federal Circuit affirmed patent validity and some infringement findings but vacated the damages award and remanded issues for further proceedings; rehearing was denied in December 2014. A district court had separately set a 0.98% ongoing royalty for certain adjudicated Apple products, which Apple appealed. Another Apple trial was scheduled for October 2015. Outcomes and recoveries were uncertain and could affect both cash flows and licensing prospects. Cisco prevailed on non-infringement in a separate case.
Key risks include reliance on a small number of licensees and litigation outcomes, substantial and potentially prolonged legal expense, patent validity and enforcement challenges, FRAND limits on licensing terms for certain declared standards-essential patents, uncertain product adoption and long sales cycles, and security, regulatory, and competitive risks. The company reported an accumulated deficit of $100.435 million and full valuation allowances against net deferred tax assets. Management and the auditor reported effective internal controls; the auditor issued unqualified opinions on the financial statements and internal control.
Important facts for investors to verify
- Whether the Apple remand, ongoing-royalty appeal, and later Apple litigation produce enforceable damages or recurring royalties—and what legal costs will be required.
- How Microsoft’s expanded, royalty-free license affects the patents available for future licensing and the company’s potential royalty base.
- Whether Gabriel products launched as planned and whether beta users convert into paying customers or meaningful recurring revenue.
- Cash and investment balances, operating cash burn, and the timing of future legal and commercialization costs; the filing provides no precise cash-runway forecast.
- The treatment and payment timing of the $6.1 million Leidos royalty, and the related-party aircraft arrangement and prepaid promotional lease.
- Potential dilution from options, restricted stock units, and warrants, as well as the impact of warrant fair-value changes on reported earnings.